SpaceLabs Medical
This article was originally published in The Gray Sheet
Executive Summary
Board authorizes the repurchase of up to 1 mil. shares of common stock "subject to certain conditions and limitations," the firm reports. As of March 26, Spacelabs had 11.3 mil. shares outstanding. "Repurchase will occur in the open market from time to time and the repurchased shares will be used in conjunction with the company's stock option, stock purchase and other benefit plans"....
You may also be interested in...
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.
‘Clear’ Is In The Eye Of The Beholder, New York, CRN Argue In Age-Restricted Sales Litigation
CRN’s request for clarification, as it continues litigating complaint in US District Court for Southern New York, highlights what it contends is vague and overly general language in the legislation passed in October with a 22 April effective date.